Latest filing published 01 Oct 2026 for Biomarin Pharmaceutical INC, €216k.
This profile gathers the share dealings of Gregory R. Friberg in Biomarin Pharmaceutical Inc. In total, 8 filings cover trades dated from 30 September 2024 to 30 September 2026.
Every open-market trade on record is a sale: 1 sale worth €323k. Besides market trades, the filings include 7 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 1 October 2026: a share grant of €216k, in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations